Published in:

01-09-2003 | ORIGINAL ARTICLE

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

Authors: Yasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, Tatsuo Shiigai, Yasuhiko Tomino, Kenichi Yamada, Takeyuki Kitajima, Terukuni Ideura, Akio Koyama, Tetsuzo Sugisaki, Hiromichi Suzuki, Satoshi Umemura, Yoshindo Kawaguchi, Shunya Uchida, Michio Kuwahara, Tsutomu Yamazaki, for the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators

Published in: Clinical and Experimental Nephrology | Issue 3/2003